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Cindy Elizabeth De Lira-Quezadaa,b, and Rosa Ivett Guzman-Avilana,bPurpose of review
Asthma is a chronic heterogeneous respiratory disease which is characterized by airflow limitation and
variable respiratory symptoms. Asthma in patients more than 65 years of age has an important negative
impact on quality of life. The pathophysiology and treatment of asthma in older patients are not as well
identified as in younger groups of ages. In this review we intend to outline characteristics found in elderly
adults which distinguish them from other age groups of patients with asthma.
Recent findings
With increasing age, there are alterations in the innate and adaptive immune responses, known as
‘immunosenescence.’ These age-associated modifications include an altered response after a pathogenic
exposure or tissue injury, moderately mediated through an irreversible loss of cellular replication and
defective tissue repair.
Summary
Asthma is a consequence of complex gene–environment interactions, with diversity in clinical presentation
and the type and intensity of airway inflammation and remodeling. Age-associated changes in lung
physiology and morphology may occur and contribute to asthma. Aging is correlated with a notable
decrease in elastic recoil, greater chest wall rigidity, and poor respiratory muscle strength. Underreporting
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DOI:10.1097/ACI.0000000000000525Asthma is one of the most common chronic, non-
communicable diseases in children and adults, char-
acterized by variable respiratory symptoms and
airflow limitation [1
&
]. Asthma is a consequence of
complex gene–environment interactions, with het-
erogeneity in clinical presentation and the type and
intensity of airway inflammation and remodeling,
affecting around 334 million people [2].
As the life expectancy increases across theworld,
the number of people over the age of 65 years is
expected to nearly triple by 2050, reaching approxi-
mately 1.5 billion of 16% of the global population
by this time [3
&&
].
Patients older than 55 years have higher rates of
emergency department visits, hospitalization, and
asthma-associated healthcare cost compared with
those younger than 55. Despite this, asthma in older
adults continues to be an under-recognized and
undertreated epidemic [4].rs Kluwer Health, Inc. All rights rese
Kluwer Health, Inc. Unaa significant negative impact on measures of quality
of life (QOL) [5
&&
]. Asthma QOL has been related to
environmental triggers and to individual factors
such as asthma self-efficacy, asthma knowledge,
asthma control, and asthma phenotype [6]. The
pathophysiology and treatment of asthma in older
patients are not as well characterized as they are in
younger adults and children [6].rved. www.co-allergy.com
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KEY POINTS
 Prevalence of asthma in the elderly has increased in
recent years.
 Always consider associated comorbidities.
 Related to elevated mortality compared with other age
groups of patients with asthma.




According to the National Health Interview Survey
data, the annual prevalence of asthma in individuals




Prevalence is highest in developed countries –
for example, Australia (21%) – and lowest in devel-
oping countries – for example, China (0.2%). How-
ever, prevalence is probably substantially
underestimated in resource-poor countries, where
basic asthma medications are not available and
patients have difficulty accessing healthcare [2,3
&&
].
Asthma was once considered primarily a devel-
opmental disease of childhood; however, several
studies report that the lifetime prevalence is high
in the elderly patient, close to 13% compared with
roughly 14% in children of ages less than 18 years
old and 7.5% in adults of ages 18–74 years [3
&&
].FIGURE 1. Asthma deaths per 1000 by demographic (2007–2
and National Health Interview Survey Data for table available at:
Adapted with permission from [5&&].
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yright © 2019 Wolters Kluwer Health, Inc. UnauthThis age group of patients has the highest rates
of morbidity and mortality from its disease com-
pared with other ages. Elderly patients with asthma
are over five times more likely to die from their
disease than younger individuals. Of aged patients,
those who are female, Black, Hispanic, and from a
lower income group are at the greatest risk for
frequent hospitalizations (Fig. 1) [5
&&
].PATHOGENESIS
In the elderly, changes related to aging, decreased
immune function and other comorbidities common
in older age are overlying on asthma. Asthma in the
elderly is often associated with allergic triggers.
Owing to this, the cause of asthma in the elderly
is considered complex and multifactorial [7].
There are several age-associated changes in lung
physiology and morphology that occur and may
contribute with the presence of asthma. Aging is
correlated with a notable decrease in elastic recoil,




The consequence of the age-related modifica-
tions, including poor chest wall compliance,
decreased respiratory muscle strength, and the
macro and microscopic changes in the lung paren-
chyma, are proposed to have an important role in
altering pulmonary function. In particular, older
patients, even without lung disease, are more pro-
pense to develop obstructive and mixed patterns
with increased residual volume, and reductions in009). Source: CDC/NCHS, National Vital Statistics System
http://www.cdc.gov/nchs/products/databriefs/db94.htm.
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Cforced expiratory volume in 1 s (FEV1), FEV1/forced
vital capacity (FVC) ratio, and FVC with a discrete
change in total lung capacity [5
&&
].IMMUNOSENESCENCE
With increasing age, there are alterations in the
innate and adaptive immune response, which
impact the pathology and the treatment of asthma
in the elderly. There are two alterations in aging in
the immune responses that have been described and
can occur simultaneously: The first one, ‘immuno-
senescence,’ is a ‘blunted’ response after a patho-
genic threat or tissue injury. However, despite an
inability to proliferate, some senescent cells remain
alive, functioning at an altered capacity [8]. This
results in the second process, ‘inflammaging,’ an
increased low-grade basal systemic inflammation
which may also result from the dysregulated activi-
ties of immune cells other than CD8þ T cells (e.g.,
IL1-b, IL-6, and TNF-a) which tend to be pro-inflam-
matory as an essential part of their function [9].
The mechanisms of immunosenescence and
inflammaging are the consequence of the genetic
and environmental exposures, accumulation of
reactive oxygen species from metabolic activity,
and mutagenesis events [8].
The possible impacts of immunosenescence and
inflammaging on asthma are briefly outlined in
Table 1 [8]. Collectively, alterations in innate and
adaptive cells likely have several clinical implica-
tions including decreasing the response to vaccina-
tions and increasing rates of infections, which in
turn may exacerbate asthma, or play a role in the
inception of asthma with a later onset [8]. Further-
more, older patients with asthma may have altered
airway and systemic inflammation resembling
changes seen in a phenotype of severe asthma in
younger patients, which is often less responsive to
corticosteroid treatment [10].PHENOTYPES OF ASTHMA IN THE
ELDERLY
Elderly patients with asthma are classified upon
their age of asthma onset and duration of disease
into: long-standing asthma (LSA), late-onset asthma
(LOA), or remitting childhood asthma that recurs at
a later age. The age cutoff for the diagnosis of LOA is
not persistent: more than 12 years of age in some
studies and up to more than 65 years in others. LSA
usually initiates before the age of 12 years. Atopy
appears to have a discrete role on the evolution of
LOA in comparison with LSA. Factors predicting
LOA include smoking, new habitual snoring, new
rhinitis symptoms, chronic sinus symptoms, weight1528-4050 Copyright  2019 Wolters Kluwer Health, Inc. All rights rese
opyright © 2019 Wolters Kluwer Health, Inc. Unagain, and obesity (especially among females).
Although viral infections are common triggers for
asthma beginning, Chlamydia pneumoniae and other
atypical infections may be the cause in some
patients with LOA. Patients with LOA are likely to
have a higher baseline FEV1, and a marked bron-
chodilator response than those with LSA, who are
more likely to have irreversible or partially reversible
airway obstruction, and greater airway hyperinfla-
tion (Table 2) [5
&&
].CLINICAL PRESENTATION
The symptoms of asthma in older adults are non-
specific, and are common to other conditions that




The diagnosis of asthma in the elderly is similar
to younger patients with the presence of symptoms
including cough, wheezing, chest tightness, and
dyspnea [7]. Usually, the symptoms are worse at
night and may be triggered by physical activity.
However, compared with younger asthmatics,
elderly asthmatics have greater morbidity and lower
scores on subjective assessments of health-related
QOL. In addition to asthma symptoms, the elderly
asthmatic is more likely to report poor general
health, symptoms of depression, and limitation of
activities of daily living [3
&&
].
In at least half of elderly patients, the diagnosis
of asthma is recent. Factors that influence the diag-
nosis may be poor perception of signs and symp-
toms, presence of extrapulmonary manifestations,
effects of aging in the respiratory tract and technical
difficulties to make reliable measurements of lung
function [7].
Older patients may not report their symptom-
atology, and may attribute breathlessness to normal
aging or comorbidities such as cardiovascular dis-
ease and obesity. Underreporting of symptoms in
older adults may have many causes, including fear,
depression, cognitive impairment, social isolation,
denial, and poor medical literacy [3
&&
].
Asthma is often provoked by environmental
exposures. The Cardiovascular Health Study general
population sample of asthmatics found that asthma-
like symptomswere often brought on ormadeworse
by exposure to the following factors: dust, smoke,
and contact with animals, plants, or pollens [3
&&
].
A history of atopy is a strong predictor of asthma
in this age group, and current or previous allergic
rhinitis, sinusitis, and nasal polyps are not uncom-
mon [3
&&
]. The prevalence of atopic conditions has
expanded in general over the past decades, which
may contribute to the appearance of asthma in
elderly patients. In a minor part, asthma in therved. www.co-allergy.com 3
uthorized reproduction of this article is prohibited.
CE: Namrta; ACI/190302; Total nos of Pages: 7;
ACI 190302
Table 1. Impacts of immunosenescence and inflammaging on asthma
Immune responses Cell type Age-associated changes
Innate Neutrophils "Number of cells in BALF and neutrophil elastase in those without asthma
"Number of cells in sputum of older vs. younger patients with asthma
"Number of sputum neutrophil mediators in older patients with asthma (IL-8, MMP9)
#Chemotaxis
#Secretion of neutrophil extracellular traps, which normally function to immobilize bacteria
#Phagocytosis
"Basal production of ROS and neutrophil elastase (damages local tissues)
#Production of ROS in response to bacterial infection
Eosinophils "Degranulation of peripheral cells in response to IL-5 in older patients with asthma
#Peripheral number of cells associated with development of BHR and aging in men (Normative
Aging Study)







Epithelial cells #Ciliary beat frequency
#Barrier function because of loss of tight cellular junctions
Adaptative B-lymphocytes #Ability to produce specific, long-lasting, and diverse antibodies to antigens (e.g., vaccination
and infection)
#Naive cells produced by the bone marrow
#Total IgE
#Antigen-specific IgE (however, antigen sensitization in older patients with asthma not
uncommon, but its effect on asthma not clear)
T-lymphocytes #Naive T cells as thymus involutes
"Number of circulating T cells because of increase in the number of memory T cells
#Expression of CD154 (CD40L), decreasing B-cell activation, and antibody class switching
"Survival of memory CD8þ cells, possibly because of chronic cytomegalovirus stimulation
(inverted CD4:CD8 ratio in older adults with asthma, associated with decreased asthma
control
Th17 cells "Number with aging
"Number in BALF of LOA animal model
BALF, bronchoalveolar fluid lavage; BHR, bronchial hyperresponsiveness; LOA, late-onset asthma; MMP-9, matrix metallopeptidase 9; ROS, reactive oxygen
species; TLR, toll like receptor.
Adapted with permission from [8].
Outcome measures
Copelderly may be associated with allergic triggers and
sensitization to dust mites and cat. The patients
sensitized to cockroach, may have an increased risk
for asthma morbidity [7].
Results of several studies have shown that the
prevalence of allergen sensitization is high, which
supports that IgE-mediated mechanisms may be
involved in elderly asthmatics [11].COMORBIDITIES
Comorbidities contribute to the clinical complexity
of the elderly, decrease in QOL as well as poor4 www.co-allergy.com
yright © 2019 Wolters Kluwer Health, Inc. Unauthasthma management (Table 3) [5
&&
]. Gemicioglu
et al. [12] studied adults with asthma (age<65 years)
and elderly patients with asthma (age 65 years)
and found that the adherence to treatment was
similar for both groups, but decreased with the
presence of gastritis, ulcer, gastroesophageal reflux,
and coronary artery disease.
Specific comorbidities such as patients with
dementia, orthodontics, and arthritis, may contrib-
ute to the adherence of treatment. Ya´n˜ez et al. [13]
found that allergic comorbidities were most fre-
quently found (65%), followed by hypertension
(45%), gastroesophageal reflux disease (16%),Volume 19  Number 00  Month 2019
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Family history () (þ)
Obesity (þ) ()
Tobacco use (þ) ()
FEV1, forced expiratory volume in 1s.
Adapted with permission from [5
&&
].
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Cdiabetes (12%), obesity (9%), coronary diseases
(8%), osteoarthritis, arthritis (7%), hypothyroidism
(7%), and dyslipidemia (3%).
There are other important comorbidities such as
frequent falls, which are a problem for elderly
patients. Bozek et al. [14] found, in patients with
asthma and chronic obstructive pulmonary disease
(COPD), that the incidence of falls was more preva-
lent in the COPD group, with 32%, compared with
28% in patients with asthma and patients with
polytherapy, depression symptoms, hospitaliza-
tions, coronary disease, dementia, and diagnosis
of COPD or asthma have a higher risk of falling.DIAGNOSIS
For the diagnosis, clinical history and physical
examination are essential, combined with an elec-
trocardiogram, chest X-ray, and spirometry [15].
The diagnosis of asthma requires assessment of lung
function with spirometry, and demonstration of
variability by bronchodilator or corticosteroidTable 3. Main factors associated with asthma
Pharmacologic Comorbidities
Drugs interactions










FEV1, forced expiratory volume in 1s; FVC, forced vital capacity.
Modified with permission from [5
&&
].
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reversibility of airway obstruction in elderly asth-
matic patients is often reduced because of irrevers-
ible structural changes resulting from airway
remodeling [17].
The FEV1/FVC ratio decreases with aging, and
therefore, it is essential to use age-adjusted values.
With aging, bronchial hyperresponsiveness to
methacholine increases; therefore, provocation
testing may be less accurate in this age group
[18]. Bronchoprovocation challenges may be con-
traindicated in some older patients with low base-
line lung function or cardiac comorbidities.
Spirometry involves effort-dependent maneuvers
and it may be difficult for those who are frail. Poor
coordination andmuscleweakness in somepatients
may produce inaccurate readings of peak expiratory
flow [19].
Other tests such as the carbon monoxide diffus-
ing capacity of the lung may help distinguish
between asthma and COPD. Chest computed
tomography may demonstrate increased wall thick-
ness, and increased air-trapping in older patients
with asthma [20]. The use of exhaled nitric oxide
in older patients is not completely established, and
aging itself can increase exhaled nitric oxide [21].
Some studies using exhaled nitric oxide as a marker
for asthma diagnosis and a measure of control in
older patients have shown it to be beneficial,
whereas others have not [22].
Measurement of plasma brain natriuretic poly-
peptide and assessment of cardiac function with
echocardiography may also be helpful. In patients
with a history of smoking or biomass fuel exposure,
COPD and overlapping asthma andCOPD should be
considered [15].TREATMENT
The treatment of asthma is enforced at the control of







Increase in small airway disease
Increased susceptibility to infections
FEV1/FVC ratio decreases
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Outcome measures
CopAsthma is characterized by chronic airway inflam-
mation disease. Therefore, inhaled corticosteroids
are the treatment of choice [16].
The inhaled route is the best option for efficacy-
to-safety treatment of asthma; in the elderly, the
technique is a problem that may lead to poor dis-
ease control, associated with cognitive impairment
and reduced lung function in patients [5
&&
]. Older
patients may have difficulties with complex medi-
cation regimens, and prescription of multiple
inhaler devices should be avoided if possible [15].
The efficacy of asthma medications in the
elderly is limited. Side-effects of b2-agonists such
as cardiotoxicity, and corticosteroid side-effects are
more common in the elderly [15]. In the manage-
ment of patients with LOA is of most importance
taking comorbidities into account because a high
number of prescribed medications may increase the
risk of drug interactions, negative impact on effi-
cacy, safety, and worsen adherence with controller
medication for asthma.
Psychologic diseases like depression and anxiety
in patients with LOA are important; they have
been associated with poor outcome in the manage-
ment, including higher exacerbation rate and mor-
tality [16].
Westerhof et al. [17] determined the remission
rate and identified predictors of persistent adult-
onset asthma and found that patients with persis-
tent asthma were older, had worse asthma control,
required higher doses of inhaled corticosteroids, had
more severe airway hyperresponsiveness, more
often presented nasal polyps, and higher levels of
blood neutrophils as compared to patients who
experienced clinical remission.DISCUSSION
Unlike younger adults and children with asthma
who encounter overdiagnosis and in some cases
an excess in treatment, older people with asthma
continue to present the highest mortality and are
underdiagnosed which may imply not receiving the
most adequate therapy measures [15]. Previous
reviews have considered as well the challenges of
treating asthma in older people because of the con-
fusion of distinguishing between comorbidities
such as COPD or gastroesophageal reflux disease
which may converge with asthma in a later lifetime
period [24]. Along with the comorbidities are risk
factors and distinct clinical outcomes, described
previously by Bennet et al. [4] in which independent
risk factors associated with fixed air obstruction
include male sex, older age, and increased duration
of asthma [25].6 www.co-allergy.com
yright © 2019 Wolters Kluwer Health, Inc. UnauthCONCLUSION
Asthma in the elderly is a disease that negatively
affects the functionality and QOL of individuals.
The lack of diagnosis associated with the changes
of aging in the respiratory system and the multiple
comorbidities make it difficult to establish treat-
ments effective for its control. Current evidence
shows that the elderly benefit from a stepped treat-
ment, as do young patients with asthma, requiring
the monitoring of the adverse effects of both corti-
costeroids and bronchodilators to ensure good con-
trol and therapeutic adherence. In view of the
demographic and epidemiological transition, it is
necessary that physicians from all branches dedi-
cated to health of the elder form multidisciplinary
teams that ensure quality medical care.
Acknowledgements
None.
Financial support and sponsorship
This work was supported by the Regional Center of
Allergy and Clinical Immunology. Universidad Auton-
oma de Nuevo Leo´n, Facultad de Medicina, University
Hospital ‘Dr Jose´ Eleuterio Gonza´lez’. Monterrey, Nuevo
Leo´n, Mexico.
No funding was received for this work from National
Institutes of Health (NIH); Wellcome Trust; Howard
Hughs Medical Institute (HHMI); or others.
Conflicts of interest
There are no conflicts of interest.REFERENCES AND RECOMMENDED
READING
Papers of particular interest, published within the annual period of review, have
been highlighted as:
& of special interest
&& of outstanding interest1.
&
Cavalazzi R, Jorayeva A, Beatty B, et al. Predicting asthma in older adults on
the basis of clinical history. Respir Med 2018; 142:36–40.
This article provides a diagnostic accuracy study using methacholine challenge
test to obtain positive predictors for asthma in elderly patients.
2. Papi A, Brightling C, Pedersen SE. Asthma. Lancet 2018; 391:783–800.
3.
&&
Pasha MA, Sundquist B, Townley R. Asthma pathogenesis, diagnosis, and
management in the elderly. Allergy Asthma Proc 2017; 38:184–191.
Pasha et al. highlight the challenges presented by physicians regarding the burden of
high medical costs and alsoemphasize the high mortality in elderly patients with asthma.
4. Bennet GH, Carpenter L, Hao W, et al. Risk factors and clinical outcomes
associated with fixed airflow obstruction in older adults with asthma. Ann
Allergy Asthma Immunol 2018; 120:164–168.
5.
&&
Dunn RM, Busse PJ, Wechsler ME. Asthma in the elderly and late-onset adult
asthma. Allergy 2018; 73:284–294.
This article by Dunn et al. provides accurate, recent, and useful data regarding age-
related physiologic and immunologic changes in elderly patients with asthma,
providing a better understanding of the underlying causes and mechanisms involved.
6. Polivka BJ, Folz R, Myers J, et al. Identifying phenotypes and factors impacting
outcomes in older adults with asthma: a research protocol and recruitment
results. Research in Nursing and Health 2018; 41:336–345.
7. Nagaratnam N, Nagaratnam K, Cheuk G. Asthma in the elderly. Geriatric
diseases. Evaluation and Management. 1st edition. Springer International
Publishing; 2010; 99–104.Volume 19  Number 00  Month 2019
orized reproduction of this article is prohibited.
CE: Namrta; ACI/190302; Total nos of Pages: 7;
ACI 190302
Asthma in elderly Gonzalez-Diaz et al.
C8. Baptist AP, Busse PJ. Asthma over the age of 65: all’s well that ends well. J
Allergy Clin Immunol: In Practice 2018; 3:764–773.
9. Pawalec G. Age and immunity: what is immunosenescence? Exp Gerontol
2018; 105:4–9.
10. Fulop T, Larbi A, Dupuis G, et al. Immunosenescence and inflamm-aging as
two sides of the same coin: friends of foes? Front Immunol 2018; 8:1960.
11. Braman SS. Asthma in the elderly. Clin Geriatr Med 2017; 33:523–537.
12. Gemicioglu B, Bayram H, Cimrin A. Asthma control and adherence in newly
diagnosed young and elderly adult patients with asthma in Turkey. J Asthma
2018; 6:1–9.
13. Ya´n˜ez A, Soria M, De Barayazarra S, et al. Clinical characteristics and
comorbidities of elderly asthmatics who attend allergy clinics. Asthma Res
Pract 2018; 4:5.
14. Bozek A, Jarzab J, Hadas E, et al. Fall episodes in elderly patients with asthma
and COPD: a pilot study. J Asthma 2018; 8:1–5.
15. Ulrik CS. Late-onset asthma: a diagnostic and management challenge. Drugs
Aging 2017; 34:157–162.
16. Hirano T, Matsunaga K. Late onset asthma: current perspectives. J Asthma
Allergy 2018; 11:19–27.
17. Westerhof GA, Coumou H, de Nijs SB, et al. Clinical predictors of remission
and persistence of adult-onset asthma. J Allergy Clin Immunol 2018;
141:104–109.1528-4050 Copyright  2019 Wolters Kluwer Health, Inc. All rights rese
opyright © 2019 Wolters Kluwer Health, Inc. Una18. Vaz Fragoso CA, McAvay G, Van Ness PH, et al. Phenotype of normal
spirometry in an aging population. Am J Respir Crit Care Med 2015;
192:817–825.
19. Luoto JA, Elmstahl S, Wollmer P, et al. Incidence of airflow limitation in
subjects 65–100 years of age. Eur Respir J 2016; 47:461–472.
20. Inoue H, Niimi A, Takeda T, et al. Pathophysiological characteristics of asthma
in the elderly: a comprehensive study. Ann Allergy Asthma Immunol 2014;
113:527–533.
21. Toren K, Murgia N, Schioler L, et al. Reference values of fractional excretion of
exhaled nitric oxide among nonsmokers and current smokers. BMC Pulm Med
2017; 17:118.
22. Malerba M, Damiani G, Carpagnano GE, et al. Values in elderly people for
exhaled nitric oxide study. Rejuv Res 2016; 19:233–238.
23. Global Initiative for Asthma. Global Strategy for Asthma Management and
Prevention 2018 (cited 2018 Oct 31). Available from: https://ginasthma.org/
2018-gina-report-global-strategy-for-asthma-management-and-prevention/.
[Accessed 1 October 2018]
24. Gibson PG, McDonald VM, Marks GB. Asthma in older adults. Lancet 2010;
376:803–813.
25. Zhang L, He L, Gong J, et al. Risk Factors Associated with Irreversible Airway
Obstruction in Asthma: A Systematic Review and Meta-Analysis BioMed
Research International 2016; 2016.rved. www.co-allergy.com 7
uthorized reproduction of this article is prohibited.
